SCHEMBL385089

SCHEMBL385089

C=C[Sn](C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL389627 0.74
SCHEMBL1030044 0.70
SCHEMBL6996643 0.59
SCHEMBL11450863 0.59
SCHEMBL1180981 0.59
SCHEMBL6996638 0.59
SCHEMBL390121 0.59
Propene SCHEMBL4948068 0.54 TSHR (0.33)
Propene SCHEMBL8431129 0.54 TSHR (0.33)
SCHEMBL2956825 0.54

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4626872-A1 CHEMOENZYMATIC SYNTHESIS OF POLYKETIDES Aspera Biomedicines, Inc. (US) 2025-10-08 EP claimed
WO-2024119114-A1 CHEMOENZYMATIC SYNTHESIS OF POLYKETIDES ASPERA BIOMEDICINES, INC. (US) 2024-06-06 WO claimed
EP-2223946-B1 Modified natural rubber or modified natural rubber latex and rubber composition BRIDGESTONE CORP (JP) 2012-08-22 EP claimed
US-8101697-B2 Multi-functionalized high-trans elastomeric polymers BRIDGESTONE CORPORATION (JP) 2012-01-24 US claimed
US-20060173145-A1 Multi-functionalized high-trans elastomeric polymers BRIDGESTONE CORPORATION (JP) 2006-08-03 US claimed
US-6362357-B1 PHOSPHINE; USING ARYL HALIDES; ORGANOTIN COMPOUNDS UNIVERSITY OF NEW ORLEANS RESEARCH & TECHNOLOGY FOUNDATION 2002-03-26 US claimed
WO-2001066248-A2 C-C AND C-N COUPLING CATALYST COMPRISING TRANSITION METAL AND CARBENE UNIVERSITY OF NEW ORLEANS RESEARCH AND TECHNOLOGY FOUNDATION (US) 2001-09-13 WO claimed
EP-4626872-A1 CHEMOENZYMATIC SYNTHESIS OF POLYKETIDES Aspera Biomedicines, Inc. (US) 2025-10-08 EP disclosed
WO-2024119114-A1 CHEMOENZYMATIC SYNTHESIS OF POLYKETIDES ASPERA BIOMEDICINES, INC. (US) 2024-06-06 WO disclosed
US-20230374017-A1 COMPOSITIONS AND METHODS FOR ACTIVATING PYRUVATE KINASE THE REGENTS OF THE UNIVERSITY OF MICHIGAN 2023-11-23 US disclosed
EP-3860975-B1 MODULATORS OF HEMOGLOBIN FOR THE TREATMENT OF SICKLE CELL DISEASE GLOBAL BLOOD THERAPEUTICS INC (US) 2023-10-18 EP disclosed
CN-116249531-A Compositions and methods for activating pyruvate kinase 密执安大学评议会 2023-06-09 CN disclosed
EP-4185293-A1 COMPOSITIONS AND METHODS FOR ACTIVATING PYRUVATE KINASE The Regents of The University of Michigan (US) 2023-05-31 EP disclosed
US-6235734-B1 TOBACCO ADDICTION PFIZER INC 2001-05-22 US disclosed
EP-0968158-A1 METHOD OF PREPARING SUBSTITUTED INDANONES, THE SUBSTITUTED INDANONES AND METALLOCENES PREPARED THEREFROM Basell Polyolefine GmbH (DE) 2000-01-05 EP disclosed
WO-1998040331-A1 PREPARATION OF PREPARING SUBSTITUTED INDANONES TARGOR GMBH (DE) 1998-09-17 WO disclosed
US-5494666-A BETA-LACTAMASE INHIBITORS, ANTIBACTERIALS HOFFMANN-LA ROCHE INC. (US) 1996-02-27 US disclosed
US-5464617-A 1H-2,6a-diazacyclobut(cd)indene-6-carboxylic acid derivatives, antibiotics HOFFMANN-LA ROCHE INC. (US) 1995-11-07 US disclosed
EP-0671401-A1 Beta lactames F. HOFFMANN-LA ROCHE AG (CH) 1995-09-13 EP disclosed
WO-1993022291-A1 ARTHROPODICIDAL AND FUNGICIDAL AMINOPYRIMIDINES E.I. DU PONT DE NEMOURS AND COMPANY (US) 1993-11-11 WO disclosed